Zobrazeno 1 - 10
of 77
pro vyhledávání: '"Shikiar, Richard"'
Publikováno v:
Tobacco Control, 2001 Sep 01. 10(3), 233-238.
Externí odkaz:
https://www.jstor.org/stable/20207930
Publikováno v:
Health and Quality of Life Outcomes, Vol 4, Iss 1, p 71 (2006)
Abstract Background Patient-reported outcome (PROs) measures are being used more frequently in investigational studies of treatments for moderate to severe plaque psoriasis. The objective of this study was to examine the relationships among the Derma
Externí odkaz:
https://doaj.org/article/5f88183884c64bc89c87d8e20748fb8b
Autor:
Shikiar Richard, Green Hannah, Flood Emuella M, Beusterien Kathleen M, Baran Robert W, Amonkar Mayur M, Cella David
Publikováno v:
Health and Quality of Life Outcomes, Vol 4, Iss 1, p 42 (2006)
Abstract Background The Osteoporosis Patient Satisfaction Questionnaire (OPSAT-Q) is a new measure of patient satisfaction with bisphosphonate treatment for osteoporosis. The objective of this study was to evaluate the psychometric characteristics of
Externí odkaz:
https://doaj.org/article/0f7cb1f850aa4432a75acbcc66fecb13
Publikováno v:
Health and Quality of Life Outcomes, Vol 3, Iss 1, p 36 (2005)
Abstract Background The Dermatology Quality Life Index (DLQI) has seen widespread use as a health-related quality of life measure for a variety of dermatological diseases. The purpose of this study was to estimate the minimal important difference (MI
Externí odkaz:
https://doaj.org/article/581315f58a27452881682ab3f9b27096
Autor:
Koo John, Thompson Christine, Stone Stephen P, Bresnahan Brian W, Shikiar Richard, Revicki Dennis A
Publikováno v:
Health and Quality of Life Outcomes, Vol 1, Iss 1, p 53 (2003)
Abstract Background Two Phase III randomized controlled clinical trials were conducted to assess the efficacy, safety, and tolerability of weekly subcutaneous administration of efalizumab for the treatment of psoriasis. Patient reported measures of p
Externí odkaz:
https://doaj.org/article/fd8bf1e18acf412cb86bb20921dae0af
Publikováno v:
In Journal of the American Pharmaceutical Association March 2000 40(3):402-416
Autor:
Shikiar, Richard1 (AUTHOR), Heffernan, Michael2 (AUTHOR), Langley, Richard G.3 (AUTHOR), Willian, Mary K.4 (AUTHOR), Okun, Martin M.5 (AUTHOR), Revicki, Dennis A.6 (AUTHOR) dennis.revicki@unitedbiosource.com
Publikováno v:
Journal of Dermatological Treatment. Feb2007, Vol. 18 Issue 1, p25-31. 7p. 3 Charts.
Autor:
Shikiar, Richard1 rich.shikiar@unitedbiosource.com, Willian, Mary Kaye2 mary.willian@abbott.com, Okun, Martin M.3 martin.okun@abbott.com, Thompson, Christine S.1 chris.thompson@unitedbiosource.com, Revicki, Dennis A.1 dennis.revicki@unitedbiosource.com
Publikováno v:
Health & Quality of Life Outcomes. 2006, Vol. 4, p71-12. 12p.
Autor:
Shikiar, Richard1 Shikiar@medtap.com, Harding, Gale2 Harding@medtap.com, Leahy, Michael3 Michael.Leahy@sanofi-aventis.com, Lennox, Richard D.4 Rlennox@psychometricstech.com
Publikováno v:
Health & Quality of Life Outcomes. 2005, Vol. 3, p36-5. 5p.